Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti Inflammatory Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover high-purity indole-dihydronaphthalene intermediates via novel Rh/Pd dual catalysis. Enhanced enantioselectivity and cost-effective manufacturing for pharma.
Patent CN108610253B details a green one-step Suzuki coupling for Flubensalicylic acid. Achieve 98.37% yield with ligand-free palladium catalysis for cost-effective manufacturing.
Patent CN103992212B details a novel cis-benvitimod synthesis enabling high-purity standards and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN106674179B reveals a mild, metal-free route to novel 6'-aminoluteolin derivatives. Discover cost-effective manufacturing strategies for next-generation NSAID intermediates.
Novel synthesis route for nedocromil intermediate ensures high purity and stable supply. Optimized process reduces manufacturing complexity for global pharmaceutical partners.
Novel 3-step modular synthesis of indomethacin analogues via Pd-catalyzed C2 functionalization. Reduces steps and enhances supply chain reliability for API manufacturing.
Patent CN117586274B reveals novel forskolin ring-expansion synthesis. Offers high-purity intermediates with streamlined scalability for global pharmaceutical supply chains.
Patent CN103467228A details a mild Pd-catalyzed allyl-aryl coupling for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and robust supply chain reliability.
Patent CN112521290B reveals a copper-catalyzed route for celecoxib intermediates. Discover cost reduction in pharmaceutical manufacturing and scalable supply solutions.
Patent CN109665999B details a novel U-type template strategy for meta-selective C-H activation, offering cost reduction in API manufacturing and scalable routes for high-purity intermediates.
Novel phase-transfer catalysis process for anti-inflammatory intermediates. Reduces dialkylation impurities and simplifies purification for cost-effective API manufacturing.
Patent CN115536605A details Ir-catalyzed oxazole synthesis. Offers cost-effective routes for COX-2 inhibitors. Reliable pharma intermediate supplier.
Novel U-shaped template strategy for meta-C-H olefination. Reduces steps and costs for API intermediates. High purity and scalability for pharmaceutical manufacturing.
Novel Rose Bengal catalyzed method for alpha-indole glycine derivatives offers green, scalable production for pharmaceutical intermediates.
Solve N-acyl indole synthesis challenges with high-yield, one-step palladium-catalyzed method. Reduce costs and supply risks for drug development.
Discover a one-step, high-yield method for N-acyl indole synthesis with broad substrate tolerance. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve 1,2,3-triazole synthesis challenges: 91% yield, one-pot process, reduced purification costs. CDMO expertise for scalable API production.
Struggling with low mesalazine yields? Discover emerging green synthesis methods boosting output by 10-20% and purity to 99%. Find reliable suppliers for API production.